Buy Tezspire (tezepelumab-ekko) Online

$6,250.00

DISEASE INDICATIONS: Asthma

MANUFACTURER: Amgen / AstraZeneca AB

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

 

Tezspire (tezepelumab-ekko) is a medication prescribed as an add-on maintenance treatment for individuals aged 12 years and older, both adult and pediatric, with severe asthma.

Buy Yupelri (revefenacin) Online For Sale

DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

MANUFACTURER: Theravance Biopharma

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

 

Yupelri (revefenacin) is a medication approved by the Food and Drug Administration (FDA) for the treatment of patients with COPD. It improves lung function by increasing forced expiratory volume in 1 second (FEV1) and reducing symptoms such as coughing and shortness of breath.

 

Buy Symkevi (tezacaftor/ivacaftor) Online For Sale

$5,348.00

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

 

Symkevi (tezacaftor/ivacaftor) is a tablet medicine approved for the treatment of cystic fibrosis (CF) patients who are 12 years or older. Each tablet contains 100mg of tezacaftor and 150mg of ivacaftor and must be taken in conjunction with another medicine that contains 150mg of ivacaftor alone. The medicine is sold under the brand name Symkevi in Europe and Symdeko in the United States.

Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online For Sale

$705.00

DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma

MANUFACTURER: GlaxoSmithKline

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

 

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is prescribed as a continuous, maintenance therapy for individuals with asthma and chronic obstructive pulmonary disease (COPD).

Buy Lucaftor (lumacaftor/ivacaftor) Online

$2,851.00

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Gador SA

USAGE: Oral

MEDICINE APPROVED BY:

ANMAT (ARG)

 

Lucaftor (lumacaftor/ivacaftor) is a medication prescribed to treat cystic fibrosis (CF) in patients aged 12 years or above who have two copies of the F508del mutation (F508del/F508del) in the CFTR gene.

Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online For Sale

$285.00

DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

MANUFACTURER: AstraZeneca Pharmaceuticals LP

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

 

Breztri Aerosphere, including budesonide, glyrrolate and formoterol fumarate, is a drug that helps with the long-term maintenance of patients struggling with chronic obstructive pulmonary disease (COPD).

Buy Clenbuterol Harasawa Online For Sale

$96.00

DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)

MANUFACTURER: Harasawa

USAGE: Oral

MEDICINE APPROVED BY:

Pharmaceuticals and Medical Devices Agency (PMDA)

 

Clenbuterol is a drug utilized to treat individuals with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence. It is sometimes prescribed by physicians to treat patients with ALS for off-label use. Clenbuterol was formerly recognized by its brand name, TONIL (clenbuterol).

Buy Kalydeco (ivacaftor) Online For Sale

From $6,759.00

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Kalydeco (ivacaftor) is a medication that is approved for the treatment of cystic fibrosis (CF) in patients aged 4 months and above who possess at least one mutation in their CF gene that is receptive to Kalydeco.

Buy Symdeko (tezacaftor / ivacaftor) Online For Sale

$36,792.00

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Symdeko (tezacaftor/ivacaftor) is a medication intended for the treatment of cystic fibrosis (CF) patients who are 6 years and older. Available in tablet form, each tablet contains 100mg of tezacaftor and 150mg of ivacaftor and is recommended to be taken with another medicine containing ivacaftor alone, which has a strength of 150mg. The medication is marketed in the United States as Symdeko and in Europe as Symkevi.